Home/Filings/4/0001486189-21-000005
4//SEC Filing

Breslin Terence Martin 4

Accession 0001486189-21-000005

CIK 0001479681other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 1:58 PM ET

Size

5.9 KB

Accession

0001486189-21-000005

Insider Transaction Report

Form 4
Period: 2021-01-28
Breslin Terence Martin
Director10% Owner
Transactions
  • Award

    Director Stock Option (right to buy)

    2021-01-28$1.61/sh+45,000$72,450130,120 total
    Exercise: $1.61From: 2021-01-28Exp: 2028-01-28Common Stock (45,000 underlying)
Holdings
  • Common Stock

    724,496
Footnotes (1)
  • [F1]Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger.

Issuer

Clinigence Holdings, Inc.

CIK 0001479681

Entity typeother

Related Parties

1
  • filerCIK 0001793402

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 1:58 PM ET
Size
5.9 KB